The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors

SRI Investing and Other Investing Strategies Report

January 09, 2012

Buy ($175)

Topics covered: Volatile Market, Quantitative Investing, Limiting Market Risk, Impact Investing Strategy

Companies covered: Amazon.com, Inc. (NASDAQ:AMZN), Alphabet Inc (NASDAQ:GOOG), General Electric Company (NYSE:GE)

Hedging Against Market Risk By Using Alternative Investing Strategies - Richard Bregman - MJB Asset Management
Richard Bregman
Impact Investing in Bonds - Michelle Rogers - Community Capital Management
Michelle Rogers
Impact Investing for Global Economic Growth - Gloria S. Nelund - TriLinc Global
Gloria S. Nelund
Investing in Volatility in a Tense Geopolitical Environment - Charles K. Ortel - Newport Value Partners, L.L.C.
Charles K. Ortel
Dynamic Approach to Determining Returns in Various Markets - Geoffrey Gerber - TWIN Capital Management, Inc.
Geoffrey Gerber
Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the CEO: Pasithea Therapeutics Corp. (NASDAQ:KTTA)
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Profitability Strategy Pays Off for Bank IT Company Q2 Holdings
Three Mid-Cap Names Using Their Balance Sheets to Create Value
Look Beyond Traditional Emerging Markets for More Diversification, Less Risk
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy